Mufg Americas Holdings Corp Aerie Pharmaceuticals Inc Transaction History

Mufg Americas Holdings Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 07, 2018	SELL	$51.15 - $61.0 $4,654 - $5,551	-91 Reduced 23.04%	304 $16,000
Q3 2017 Nov 13, 2017	BUY	$48.6 - $60.1 $437 - $540	9 Added 2.33%	395 $0
Q2 2017 Aug 07, 2017	BUY	N/A	386	386 $0

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Mufg Americas Holdings Corp, based on Form 13F filings with the SEC.

Stay updated on Mufg Americas Holdings Corp with notifications on news.